BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1290703)

  • 21. Optimizing radiation therapy of brain tumours by combination of 5-bromo-2-deoxy-uridine & 2-deoxy-D-glucose.
    Kalia VK
    Indian J Med Res; 1999 May; 109():182-7. PubMed ID: 10643143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comment on "survival improvement in anaplastic astrocytoma, combining external radiation with halogenated pyrimidines: final report of RTOG 86-12, Phase I-II Study".
    Phillips TL
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1281-2. PubMed ID: 8985057
    [No Abstract]   [Full Text] [Related]  

  • 23. Fast neutron radiation therapy.
    Cohen L; Awschalom M
    Annu Rev Biophys Bioeng; 1982; 11():359-90. PubMed ID: 6808894
    [No Abstract]   [Full Text] [Related]  

  • 24. Radiosensitization of malignant brain tumours with bromouridine (thymidine analogue).
    Hoshino T; Sano K
    Acta Radiol Ther Phys Biol; 1969; 8(1-2):15-26. PubMed ID: 5800876
    [No Abstract]   [Full Text] [Related]  

  • 25. [Radiotherapy of brain tumors].
    Sano K
    Nihon Ishikai Zasshi; 1969 Feb; 61(3):283-99. PubMed ID: 5814610
    [No Abstract]   [Full Text] [Related]  

  • 26. [Radiotherapy combined with halogenated pyrimidines--fundamental and clinical studies (author's transl)].
    Takahashi M
    Nihon Gan Chiryo Gakkai Shi; 1975 Sep; 10(3):278-94. PubMed ID: 1240108
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Yuan X; Dillehay LE; Williams JR; Williams JA
    Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of radiosensitizing agents in radiotherapy].
    Franke HD
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:199-201. PubMed ID: 4115508
    [No Abstract]   [Full Text] [Related]  

  • 29. [The radiation therapy of experimental brain tumors by using the radiosensitizing preparation xanthobin (8-bromocaffeine)].
    Vartanian LP; Rudenko IIa; Volchkov VA
    Med Radiol (Mosk); 1989 Nov; 34(11):82-3. PubMed ID: 2586265
    [No Abstract]   [Full Text] [Related]  

  • 30. [Trial and results of improved radiotherapy for cancer. 5. Radiotherapy with simultaneous administration of radio-sensitizing agents. Administration of halogenated pyrimidine].
    Tanaka N; Takahashi M
    Nihon Rinsho; 1972 Dec; 30(12):2655-8. PubMed ID: 4675997
    [No Abstract]   [Full Text] [Related]  

  • 31. Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. I. Radiosensitization of human colon cancer cells by iododeoxyuridine.
    Miller EM; Fowler JF; Kinsella TJ
    Radiat Res; 1992 Jul; 131(1):81-9. PubMed ID: 1626052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of non-hypoxic cell sensitizers in radiobiology and radiotherapy.
    Mitchell JB; Russo A; Kinsella TJ; Glatstein E
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1513-8. PubMed ID: 3531118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1977 Henry H. Janeway lecture: fundamental mechanisms in combined modality therapy of cancer.
    Kaplan HS
    AJR Am J Roentgenol; 1977 Sep; 129(3):383-93. PubMed ID: 409189
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of 5-bromodeoxyuridine and 5-iododeoxyuridine on a latent herpes simplex virus infection.
    Varani J; Kelleher JJ
    Antimicrob Agents Chemother; 1975 Jul; 8(1):18-21. PubMed ID: 1172408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure.
    Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1393-8. PubMed ID: 2370189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and experimental results of interstitial Curie-therapy combined with radiosensitizing agents in DS carcinoma of the rat and in infiltrating brain neoplasms].
    Mundinger F
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:201. PubMed ID: 4341101
    [No Abstract]   [Full Text] [Related]  

  • 37. [Application of radiosensitizer, 5-bromodeoxyuridine, to head and neck tumors].
    Tanaka Y; Takahashi M; Kuroda Y; Ota F; Monju T
    Rinsho Hoshasen; 1969 Oct; 14(10):765-75. PubMed ID: 5196172
    [No Abstract]   [Full Text] [Related]  

  • 38. Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers.
    Coleman CN
    Semin Oncol; 1989 Jun; 16(3):169-75. PubMed ID: 2658080
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.
    Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
    Radiat Res; 1990 Aug; 123(2):192-8. PubMed ID: 2389005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical radiosensitization: why it does and does not work.
    Coleman CN; Mitchell JB
    J Clin Oncol; 1999 Jan; 17(1):1-3. PubMed ID: 10458210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.